Pharmaceutical Technology

NOVEMBER 14, 2022

In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells. All five patients achieved remission after three months.

Side effects 144

Side effects Patients Manufacturing Safety 144

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Pharma Marketing Network

MARCH 25, 2022

Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team. Caregiver observations of the patient experience over the progression of the disease may inform the safety and efficacy of a particular therapeutic. Sunny White.

Pharma 98

Pharma Education Transportation Training 98

European Pharmaceutical Review

JANUARY 29, 2024

4 The use of CPCA assessments allows for the assignment of scientifically justifiable higher acceptable intakes (AIs), without impacting patient safety. 16 Hydrazoic acid is a toxic, explosive gas and presents a significant worker-safety risk during manufacture of valsartan drug substance. 2011 Dec;12(4):1248-63.

Pharmaceutical 94

Pharmaceutical Food and Drug Administration Medicine FDA 94

Pharmaceutical Technology

SEPTEMBER 13, 2022

Since the approval of the first ICI – Bristol-Myers Squibb's (BMS) Yervoy (ipilimumab) in 2011 for unresectable metastatic melanoma – multiple checkpoint inhibitors have been approved in this disease setting. Patients in the adjuvant arm underwent surgery followed by 18 cycles of Merck’s Keytruda (pembrolizumab).

Patients 69

Patients Physicians Safety Pharma 69

Clarify Health

AUGUST 26, 2020

The medical loss ratio (MLR), also known as the medical cost ratio (MCR), is the percentage of member premiums that health insurers spend on medical care or quality improvement activities for their patient population. Prevention of hospital readmissions through discharge planning and patient-centered education.

Insurance 52

Insurance Medical Networking Management 52

Evolve Your Success

MAY 10, 2022

In a world of medical and health jargon, it can be difficult for patients to understand the kind of care they are getting. Sometimes, beyond the language, it is in the way health professionals communicate to the patient and their families as well as to each other. They are also patient advocates from their experience in nursing.

Education 52

Education Patients Medical sales reps Medical sales 52

PM360

DECEMBER 20, 2023

In 2021, a consensus was reached that classified rare diseases as those with an incidence of less than 1 in 10,000 newborns, or a prevalence of less than 1 in 10,000 adults, or a patient population of less than 140,000 in total. The GBA gives patients access to innovative drugs (e.g., References: 1. Ther Innov Regul Sci. Tomaszek, A.

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 75

Food and Drug Administration Safety Patients Leads 75

European Pharmaceutical Review

JULY 13, 2023

However, even as science advances, there remain patients who still need new treatment options. By re-engineering existing approaches that have already shown clinical promise, there is potential to bring further benefit to the patient community in its fight against cancer.

Engineering 84

Engineering Food and Drug Administration Safety Patients 84

European Pharmaceutical Review

SEPTEMBER 22, 2022

Small populations, paediatric patients, and the desire from patients and their caregivers to receive active therapy can make the conduct of randomised trials with placebo control untenable. Rare disease drug development poses unique challenges that can be overcome by using real-world evidence (RWE). Benefits of historical controls.

Food and Drug Administration 111

Food and Drug Administration Patients Distribution FDA 111

European Pharmaceutical Review

FEBRUARY 1, 2024

Even though patients are on existing [statins] that are well-documented and most likely safe and effective, there are many patients who still have cardiovascular disease, the leading cause of death” We are recognising now is that there is great data on how to reduce risk by applying lipid lowering therapy like statins.

Pharma 73

Pharma Patients Pharmaceutical Leads 73

pharmaphorum

AUGUST 22, 2022

The Health Innovation Fund aims to invest in companies that strive to help the industry progress for the betterment of healthcare providers and patients. Improving efficiency in care will translate to a much more productive system for healthcare providers and patients. Investment strategies. About the author .

Healthcare 83

Healthcare Healthcare Healthcare Provider Specialization 83

Pharmaceutical Technology

MAY 11, 2008

As a result, governments are eager to protect patients from counterfeit medication, save on the costs of fraud and introduce regulatory systems throughout the drug supply chain which can afford full accountability right back to the production facility. The pilot scheme for this has been observed by the FDA and EU Commission.

Electronics 52

Electronics Transportation Pharmaceutical manufacturing Pharmaceutical 52

Cadensee

JULY 26, 2021

it's the only reason that it was possible, because this was a hospital and they had access to the resources and the patients. And it also goes to safety, which not surprisingly, was the number one concern with parents. So also want to make sure that our branding and our packaging really communicates the safety of the product.

Retail 52

Retail Marketing Doctors Food 52

Cadensee

OCTOBER 19, 2021

22:15 Doesn't the scoring system create more anxiety with the patient? Will the patients know how to act upon it when there is no 100% certainty? 24:27 Do you give patients the option to call a live person and discuss or get clarifications on the report? And it is a life changing event, not for the just for the patient.

Patients 52

Patients Medical Networking Marketing 52